In the last trading session, 8.43 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share price at $0.57 changed hands at $0.1 or 19.79% during last session, the market valuation stood at $9.55M. KAPA’s last price was a discount, traded about -601.75% off its 52-week high of $4.00. The share price had its 52-week low at $0.40, which suggests the last value was 29.82% up since then. When we look at Kairos Pharma Ltd’s average trading volume, we note the 10-day average is 3.14 million shares, with the 3-month average coming to 443.75K.
Kairos Pharma Ltd (AMEX:KAPA) trade information
Instantly KAPA was in green as seen at the end of in last trading. With action -3.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -62.72%, with the 5-day performance at -3.70% in the red. However, in the 30-day time frame, Kairos Pharma Ltd (AMEX:KAPA) is -24.95% down. Looking at the short shares, we see there were 85193.0 shares sold at short interest cover period of 0.62 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.37%. The 2025 estimates are for Kairos Pharma Ltd earnings to increase by 7.25%, but the outlook for the next 5-year period is at -24.45% per year.
KAPA Dividends
Kairos Pharma Ltd is expected to release its next quarterly earnings report on 2025-May-13.
Kairos Pharma Ltd (AMEX:KAPA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 47.25% of Kairos Pharma Ltd shares while 9.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 17.75%.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 16.76 shares estimated at $9494.0 under it, the former controlled 0.10% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.01% of the shares, roughly 2.47 shares worth around $1399.0.
